danthron has been researched along with Cancer of Stomach in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, JH | 1 |
| Yang, JS | 1 |
| Ma, CY | 1 |
| Yang, MD | 1 |
| Huang, HY | 1 |
| Hsia, TC | 1 |
| Kuo, HM | 1 |
| Wu, PP | 1 |
| Lee, TH | 1 |
| Chung, JG | 1 |
1 other study available for danthron and Cancer of Stomach
| Article | Year |
|---|---|
Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways.
Topics: Annexin A5; Anthraquinones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein | 2011 |